Benzoyl peroxide cream to prevent cold sore outbreaks
Part of Infections, Skin clinical trials.
This study tests whether a daily benzoyl peroxide cream can stop cold sores (caused by HSV-1) from coming back. You may join from home through video visits, and if you have an outbreak during the trial, you'll get the standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had at least two cold sore outbreaks in the past year.
- You can take part in video appointments and use a smartphone, tablet, or computer.
- You are not pregnant or planning to become pregnant during the study.
- You have no known allergy to benzoyl peroxide or similar acne products.
- You are not currently in another topical treatment trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial offers a new antiviral medicine called pritelivir to people with weakened immune systems who have herpes sores that do not get better with standard treatments. Taking pritelivir may help clear these resistant sores when other options have failed.
This trial tests whether 2LHERP® can reduce or manage frequent herpes infections around the mouth. It compares the study drug to a placebo (inactive treatment) in people who get many episodes each year.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
This study tests an investigational medication called UB-621, given as repeated doses, to see if it is safe and effective in reducing recurrent genital herpes outbreaks in adults. If you have frequent outbreaks (6 to 12 per year), this trial might help you find a new treatment option.
This study tests a new mRNA vaccine designed to protect against herpes simplex virus type 2 (HSV-2), the virus that causes genital herpes. It is for healthy adults who have not had a genital herpes outbreak in the last 6 months.
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
Hear when a new HSV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.